Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 1;107(11):2737-2741.
doi: 10.3324/haematol.2022.281586.

Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome

Igor Giarretta  1 , Walter Ageno  2 , Francesco Dentali  3
Affiliations

Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome

Igor Giarretta et al. Haematologica. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Incidence of events in patients treated with direct oral anticoagulants compared with warfarin. DOAC: direct oral anticoagulants; N: number; CI: confidence interval.
Figure 2.
Figure 2.
Comparison between patients treated with direct oral anticoagulants or warfarin. (A) Incidence of thrombotic events, (B) major bleedings, (C) arterial events and (D) venous events. DOAC: direct oral anticoagulants; N: number; CI: confidence interval; VTE: venous thromboembolism.
Figure 3.
Figure 3.
Incidence of thrombotic events in patients without history of arterial events treated with direct oral anticoagulants compared with warfarin. DOAC: direct oral anticoagulants; N: number; CI: confidence interval.
See this image and copyright information in PMC

References

    1. van Es N, Coppens M, Schulman S, Middeldorp S, Buller HR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. 2014;124(12):1968-1975. - PubMed
    1. Ruff CT, Giugliano RP, Braunwald E, et al. . Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955-962. - PubMed
    1. Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, et al. . Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus. 2011;20(2):206-218. - PubMed
    1. Keeling D, Mackie I, Moore GW, Greer IA, Greaves M. British Committee for Standards in H. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2012;157(1):47-58. - PubMed
    1. Ordi-Ros J, Saez-Comet L, Perez-Conesa M, et al. . Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial. Ann Intern Med. 2019;171(10):685-694. - PubMed

MeSH terms